Yahoo
NYSE USD

Community Health Systems, Inc. (CYH)

2.4000 -0.0100 (-0.41%)
At close: October 30 at 4:00:03 PM EDT
2.4000 0.0000 (0.00%)
After hours: October 30 at 4:00:23 PM EDT
Trade CYH on Coinbase
Chart Range Bar
Loading chart for CYH
  • Previous Close 2.4100
  • Open 2.3300
  • Bid 2.3900 x 290000
  • Ask 2.5000 x 150000
  • Day's Range 2.3200 - 2.4400
  • 52 Week Range 2.1900 - 3.9300
  • Volume 2,485,074
  • Avg. Volume 1,285,465
  • Market Cap (intraday) 338.464M
  • Beta (5Y Monthly) 1.89
  • PE Ratio (TTM) 1.30
  • EPS (TTM) 1.8500
  • Earnings Date Oct 28, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 2.86
  • Zacks Rating Neutral

Community Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States. The company offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. It also provides outpatient services at primary care practices, urgent care centers, free-standing emergency departments, ambulatory surgery centers, imaging and diagnostic centers, and direct-to-consumer virtual health visits. Community Health Systems, Inc. was founded in 1985 and is headquartered in Franklin, Tennessee.

www.chs.net

44,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CYH
23.08%
S&P 500 (^GSPC)
10.73%

1-Year Return

CYH
41.89%
S&P 500 (^GSPC)
11.11%

3-Year Return

CYH
14.29%
S&P 500 (^GSPC)
81.91%

5-Year Return

CYH
81.68%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 2.76B
Earnings -86M
Profit Margin -3.12%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
1B
2B
3B
-2.0%
0.0%
2.0%

Analyst Insights

View More

Analyst Price Targets

2.00 Low
2.86 Average
2.4000 Current
4.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/31/2026
Analyst UBS
Rating Action Maintains
Rating Neutral
Price Action Lowers
Price Target 3 -> 2.55

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.31%

  • Return on Assets (ttm)

    4.21%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    11.65B

  • Net Income Avi to Common (ttm)

    36M

  • Diluted EPS (ttm)

    1.8500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    155M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    203.25M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: